11/19
04:33 pm
htfl
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/13
04:04 pm
htfl
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $39.00 to $40.00. They now have a "buy" rating on the stock.
Medium
Report
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $39.00 to $40.00. They now have a "buy" rating on the stock.
11/13
02:22 pm
htfl
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $40.00. They now have an "overweight" rating on the stock.
11/13
11:23 am
htfl
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.
11/12
04:01 pm
htfl
Heartflow Reports Third Quarter 2025 Financial Results
High
Report
Heartflow Reports Third Quarter 2025 Financial Results
11/9
01:30 pm
htfl
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Low
Report
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
11/3
01:22 pm
htfl
Heartflow (NASDAQ:HTFL) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.
Low
Report
Heartflow (NASDAQ:HTFL) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.
11/3
08:00 am
htfl
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
Medium
Report
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
10/23
04:05 pm
htfl
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
Medium
Report
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
10/22
08:00 am
htfl
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
Medium
Report
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
9/22
04:05 pm
htfl
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
High
Report
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
9/22
08:10 am
htfl
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $35.00 to $39.00. They now have a "buy" rating on the stock.
Medium
Report
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $35.00 to $39.00. They now have a "buy" rating on the stock.